Luoxin Pharmaceuticals Group Stock Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Luoxin Pharmaceuticals Group Stock Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million ≈ $13.28 Million USD) by net assets (CN¥1.53 Billion ≈ $223.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)

Cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002793 stock price for real-time trading data and today's change.

Luoxin Pharmaceuticals Group Stock Co Ltd Cash Flow Conversion Ratio Explained

Luoxin Pharmaceuticals Group Stock Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency. Also see Luoxin Pharmaceuticals Group Stock Co Lt market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mako Mining Corp Common Stock NASDAQ:MAKO	0.137x
Amtran Technology Co Ltd TW:2489	-0.032x
Dongguan Mentech Optical & Magnetic Co Ltd SHE:002902	-0.090x
Ardmore Shipping Corporation F:A61	0.075x
CECEP Guozhen Environmental Protection Technology Co Ltd SHE:300388	0.032x
Ability Enterprise Co Ltd TW:2374	-0.010x
Enovix Corp NASDAQ:ENVX	-0.086x
Shenyang Blue Silver Ind Auto SHE:300293	-0.059x

Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. Review 002793 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.24 Billion ≈ $180.82 Million	CN¥253.07 Million ≈ $37.03 Million	0.205x	+289.35%
2024-12-31	CN¥1.46 Billion ≈ $213.56 Million	CN¥-157.85 Million ≈ $-23.10 Million	-0.108x	-150.33%
2023-12-31	CN¥2.57 Billion ≈ $376.42 Million	CN¥552.79 Million ≈ $80.89 Million	0.215x	+175.66%
2022-12-31	CN¥3.31 Billion ≈ $483.84 Million	CN¥-939.13 Million ≈ $-137.42 Million	-0.284x	-1215.03%
2021-12-31	CN¥4.74 Billion ≈ $692.99 Million	CN¥120.63 Million ≈ $17.65 Million	0.025x	+442.04%
2020-12-31	CN¥4.35 Billion ≈ $636.59 Million	CN¥-32.40 Million ≈ $-4.74 Million	-0.007x	-125.36%
2019-12-31	CN¥3.96 Billion ≈ $579.73 Million	CN¥116.33 Million ≈ $17.02 Million	0.029x	-76.59%
2018-12-31	CN¥909.89 Million ≈ $133.14 Million	CN¥114.12 Million ≈ $16.70 Million	0.125x	-7.52%
2017-12-31	CN¥754.19 Million ≈ $110.36 Million	CN¥102.27 Million ≈ $14.97 Million	0.136x	+30.19%
2016-12-31	CN¥698.33 Million ≈ $102.19 Million	CN¥72.74 Million ≈ $10.64 Million	0.104x	-39.16%
2015-12-31	CN¥339.50 Million ≈ $49.68 Million	CN¥58.12 Million ≈ $8.51 Million	0.171x	+29.11%
2014-12-31	CN¥315.46 Million ≈ $46.16 Million	CN¥41.83 Million ≈ $6.12 Million	0.133x	-48.50%
2013-12-31	CN¥251.50 Million ≈ $36.80 Million	CN¥64.75 Million ≈ $9.48 Million	0.257x	+58.84%
2012-12-31	CN¥205.54 Million ≈ $30.08 Million	CN¥33.31 Million ≈ $4.88 Million	0.162x	-47.10%
2011-12-31	CN¥151.87 Million ≈ $22.22 Million	CN¥46.53 Million ≈ $6.81 Million	0.306x	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$635.00 Million

CN¥4.34 Billion CNY

Market Cap Rank

#10696 Global

#2850 in China

Share Price

CN¥3.99

Change (1 day)

-1.72%

52-Week Range

CN¥3.80 - CN¥5.77

All Time High

CN¥25.07